Table of Contents page: Journal of Hepatology

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

EASL E-Tools

Published in issue: April 2014

ii

Editorial Board

Published in issue: April 2014

iii

Clinical School of Hepatology, Liver Cirrhosis: A Systemic Disease, Belgrade, Serbia, 2014

Published in issue: April 2014

iv

EASL Special Conference, Optimal Management of Hepatitis B Virus Infection, Athens, Greece, 2014, co-organised by APASL

Published in issue: April 2014

v

London, UK, International Liver CongressTM 2014

Published in issue: April 2014

vi

EASL Monothematic Conference; Primary Biliary Cirrhosis, Milan, Italy, 2014

Published in issue: April 2014

vii

ILC Vienna 2015, 50th Annual Congress

Published in issue: April 2014

xii

The impact of chronic hepatitis C infection on the circadian clock and sleep

Daniel Shouval

Published online: January 15, 2014

p685-686

Open Access

PSC: Novel disease associations providing pathogenetic clues?

Hanno Ehlken,
Christoph Schramm

Published online: January 15, 2014

p687-688

Open Access

Failing FXR expression in the liver links aging to hepatic steatosis

Philippe Lefebvre,
Bart Staels

Published online: January 13, 2014

p689-690

Open Access

Research Articles

Viral Hepatitis

The changing epidemiology of hepatitis C virus infection in the United States: National health and nutrition examination survey 2001 through 2010

Ivo Ditah,
Fausta Ditah,
Pardha Devaki,
...
Basile Njei,
Henry N. Luma,
Michael Charlton

Published online: December 02, 2013

p691-698

Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: Final results from the STEPS trial

D. Shoeb,
J. Dearden,
A. Weatherall,
...
G.J. Alexander,
D. Forton,
G.R. Foster

Published online: November 27, 2013

p699-705

Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®)

Thierry Poynard,
Julien Vergniol,
Yen Ngo,
...
on behalf of FibroFrance Study Group,
the Epic3 Study Group,
the Bordeaux HCV Study Group

Published online: November 27, 2013

p706-714

Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients

Thomas Berg,
Fabien Zoulim,
Bernd Moeller,
...
John F. Flaherty Jr.,
John G. McHutchison,
Michael Manns

Published online: December 02, 2013

p715-722

Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor

Shirin Nkongolo,
Yi Ni,
Florian A. Lempp,
...
Walter Mier,
Stefan Mehrle,
Stephan Urban

Published online: December 02, 2013

p723-731

Active at night, sleepy all day – Sleep disturbances in patients with hepatitis C virus infection

Meike Heeren,
Faina Sojref,
Ramona Schuppner,
...
Anita B. Tryc,
Thomas Pasedag,
Karin Weissenborn

Published online: December 04, 2013

p732-740

Minimal impact of sofosbuvir and ribavirin on health related quality of life in Chronic Hepatitis C (CH-C)

Zobair M. Younossi,
Maria Stepanova,
Linda Henry,
...
David Nelson,
Fatema Nader,
Sharon Hunt

Published online: December 11, 2013

p741-747

Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response

John M. Vierling,
Mitchell Davis,
Steven Flamm,
...
Michelle Treitel,
Janice Wahl,
Jean-Pierre Bronowicki

Published online: December 20, 2013

p748-756

Cirrhosis

Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: A multicentre randomized controlled trial

Hasnain Ali Shah,
Zahid Azam,
Javeria Rauf,
...
Om Parkash,
Amna Subhan,
Syed Mohammad Munir

Published online: December 02, 2013

p757-764

Transplantation

HOPE for human liver grafts obtained from donors after cardiac death

Philipp Dutkowski,
Andrea Schlegel,
Michelle de Oliveira,
Beat Müllhaupt,
Fabienne Neff,
Pierre-Alain Clavien

Published online: December 02, 2013

p765-772

Genetic variation in TNFA predicts protection from severe bacterial infections in patients with end-stage liver disease awaiting liver transplantation

Renata Senkerikova,
Emmeloes de Mare-Bredemeijer,
Sona Frankova,
...
Milan Jirsa,
Jaap Kwekkeboom,
Jan Sperl

Published online: December 19, 2013

p773-781

Liver Failure and Growth

A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse

Anna Moles,
Lindsay Murphy,
Caroline L. Wilson,
...
Michael Karin,
Ekihiro Seki,
Derek A. Mann

Published online: December 11, 2013

p782-791

Open Access

Cancer

Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells

Yi Wei Dong,
Rong Wang,
Qian Qian Cai,
...
Wei Wu,
Yong Hu Zhang,
Xing Zhong Wu

Published online: December 11, 2013

p792-801

Cholestasis and Autoimmune Diseases

Risk of diabetes and cardiovascular disease in patients with primary sclerosing cholangitis

Jonas F. Ludvigsson,
Annika Bergquist,
Scott M. Montgomery,
Shahram Bahmanyar

Published online: November 27, 2013

p802-808

Genetic and Metabolic Diseases

Non-alcoholic fatty liver disease: Spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study

Jill M. Abrigo,
Jiayun Shen,
Vincent W.-S. Wong,
...
Francis K.-L. Chan,
Henry L.-Y. Chan,
Winnie C.-W. Chu

Published online: November 27, 2013

p809-815

Liver adapts mitochondrial function to insulin resistant and diabetic states in mice

Andras Franko,
Jürgen-Christoph von Kleist-Retzow,
Susanne Neschen,
...
Mats Paulsson,
Markus Schubert,
Rudolf J. Wiesner

Published online: December 02, 2013

p816-823

Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity

Anne Vrieze,
Carolien Out,
Susana Fuentes,
...
Erik S. Stroes,
Albert K. Groen,
Max Nieuwdorp

Published online: December 09, 2013

p824-831

Dietary glycotoxins exacerbate progression of experimental fatty liver disease

Christopher Leung,
Chandana B. Herath,
Zhiyuan Jia,
...
Matthew J. Watt,
Josephine M. Forbes,
Peter W. Angus

Published online: December 09, 2013

p832-838

A population-based study on the prevalence of NASH using scores validated against liver histology

Jenni Hyysalo,
Ville T. Männistö,
You Zhou,
...
Jussi Pihlajamäki,
Markku Peltonen,
Hannele Yki-Järvinen

Published online: December 13, 2013

p839-846

Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice

Xuelian Xiong,
Xiaolin Wang,
Yan Lu,
...
Jian Yang,
Huijie Zhang,
Xiaoying Li

Published online: December 11, 2013

p847-854

Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends

Matthias S. Matter,
Thomas Decaens,
Jesper B. Andersen,
Snorri S. Thorgeirsson

Published online: December 04, 2013

p855-865

Open Access

Frontiers in Liver Transplantation

Ethical considerations regarding early liver transplantation in patients with severe alcoholic hepatitis not responding to medical therapy

Vincent Donckier,
Valerio Lucidi,
Thierry Gustot,
Christophe Moreno

Published online: November 27, 2013

p866-871

Open Access

Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting

Sarah Tischer,
Robert J. Fontana

Published online: November 25, 2013

p872-884

Open Access

Clinical Application of Basic Science

Notch signaling and new therapeutic options in liver disease

Carola Maria Morell,
Mario Strazzabosco

Published online: December 04, 2013

p885-890

Open Access

First case of drug rash eosinophilia and systemic symptoms due to boceprevir

Agnès Samain,
Anne-Bénédicte Duval-Modeste,
Pascal Joly,
...
Philippe Courville,
Odile Goria,
Ghassan Riachi

Published online: December 13, 2013

p891-893

Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation

Toru Ikegami,
Tomoharu Yoshizumi,
Ken Shirabe,
Yoshihiko Maehara

Published online: December 04, 2013

p894-896

Open Access

Reply to: “Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation”

Audrey Coilly,
Mylène Sebagh,
Jean-Charles Duclos-Vallée

Published online: December 04, 2013

p896-897

Open Access

DHEA and progesterone have a protective effect on ribavirin-induced hemolysis

Etienne Brochot,

Sandra Bodeau,

Eric Nguyen-Khac,

Gilles Duverlie

Published online: January 10, 2014

p897-898

Open Access

Reply to: “DHEA and progesterone have a protective effect on ribavirin-induced hemolysis”

Elisabeth Eder,
Thomas-Matthias Scherzer,
Harald Hofer,
Peter Ferenci

Published online: January 10, 2014

p898-899

Open Access

From the CUPIC study: Great times are not coming (?)

Daniel Schmidt-Martin,
Diarmaid Houlihan,
Aidan McCormick

Published online: December 26, 2013

p899-900

Open Access

Reply to: “From the CUPIC study: Great times are not coming (?)”

Christophe Hezode,

Helene Fontaine,

Yoann Barthe,
Fabrice Carrat,

Jean-Pierre Bronowicki

Published online: December 30, 2013

p900-901

Open Access

Corrigendum to: “Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia” [J Hepatol 2013;59:1073–1080]

Ding-Shinn Chen,
Stephen Locarnini,
Suzanne Wait,
...
John Ward,
Jack Wallace
the CEVHAP North Asia Workshop on Viral Hepatitis

Published online: January 17, 2014

p902-903

Masterclass 2014

Published in issue: April 2014

IBC

EASL Fellowships

Published in issue: April 2014

IFC

April 2014

Focus

Editorials

Research Articles

Viral Hepatitis

Cirrhosis

Transplantation

Liver Failure and Growth

Cancer

Cholestasis and Autoimmune Diseases

Genetic and Metabolic Diseases

Review

Special Sections

Frontiers in Liver Transplantation

Clinical Application of Basic Science

Case Report

Letters to the Editor

Corrigendum

Frontmatter